PGRMC1 and ovarian cancer: Moreover, numerous researches have shown that PGRMC1 is overexpressed in chemo‐resistant tumour cells, such as doxorubicin‐resistant and camptothecin‐resistant breast cancer cells, cisplatin‐resistant ovarian cancer cells and doxorubicin‐resistant uterine cancer cells.35